A new immunotherapy regimen in metastatic colon cancer: implications for palliative practice
Ann Palliat Med
.
2023 Jan;12(1):244-247.
doi: 10.21037/apm-22-1155.
Epub 2022 Dec 15.
Authors
Norman G Nicolson
1
,
Fabian M Johnston
1
Affiliation
1
Department of Surgery, Johns Hopkins School of Medicine, Baltimore, MD, USA.
PMID:
36571173
DOI:
10.21037/apm-22-1155
No abstract available
Keywords:
CheckMate 142; Metastatic colon cancer; immunotherapy; mismatch repair deficient.